GI CANCERS

Latest News

New Clues to Pancreatic Cancer Subtypes' Unique Vulnerabilities
New Clues to Pancreatic Cancer Subtypes' Unique Vulnerabilities

March 9th 2024

Identifying differences in pancreatic cancer subtypes could be at the center of developing targeted treatments in this challenging disease.

Cambritaxestat Wins FDA Orphan Drug Designation in Pancreatic Cancer
Cambritaxestat Wins FDA Orphan Drug Designation in Pancreatic Cancer

March 7th 2024

PD-L1 Provides Valid Biomarker for Nivolumab/Chemo in Gastric Cancer
PD-L1 Provides Valid Biomarker for Nivolumab/Chemo in Gastric Cancer

February 28th 2024

FDA Accepts Tislelizumab BLA for Advanced Gastric and GEJ Cancers
FDA Accepts Tislelizumab BLA for Advanced Gastric and GEJ Cancers

February 27th 2024

FDA Approves IND Application of IMC001 for EpCAM+ Gastrointestinal Tumors
FDA Approves IND Application of IMC001 for EpCAM+ Gastrointestinal Tumors

February 26th 2024

Video Series
Video Interviews
Podcasts

More News